Hydroxychloroquine combination risky for cancer patients with COVID-19: study

Cancer patients with COVID-19 who were treated with a drug combination promoted by U.S. President Donald Trump to counter the coronavirus were three times more ... Read more

Bron:

Reuters: Health News